Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545381 - 545400 out of 553697 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EE05) mirdametinib | GOMEKLI 2MG CAP | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neurofibromatosis 1;Neurofibroma, Plexiform | SpringWorksTherapeutics,Inc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 100MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 100MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 125MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 125MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG CAP | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 100MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 100MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 125MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 125MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FEMARA CO-PACK | 49 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FEMARA CO-PACK | 70 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FEMARA CO-PACK | 91 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FEMARA CO-PACK | 70 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FEMARA CO-PACK | 91 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FCT 200MG TAB, 21(200MG) DAILY PKT | 1X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EF02) ribociclib (adm: O) | KISQALI FCT 200MG TAB, 21(200MG) DAILY PKT | 1X21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
Pages
